240 related articles for article (PubMed ID: 38244579)
1. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
4. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
6. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
7. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Chen Y; Li ZY; Zhou GQ; Sun Y
Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
9. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
Front Immunol; 2022; 13():961695. PubMed ID: 36389709
[TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.
Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma.
Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS
Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294
[TBL] [Abstract][Full Text] [Related]
13. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
15. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
[TBL] [Abstract][Full Text] [Related]
16. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
17. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
18. A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.
Du K; Zou J; Wang B; Liu C; Khan M; Xie T; Huang X; Shen P; Tian Y; Yuan Y
Front Immunol; 2022; 13():857934. PubMed ID: 35844514
[TBL] [Abstract][Full Text] [Related]
19. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
Ding Z; Li H; Yu D
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]